-+ 0.00%
-+ 0.00%
-+ 0.00%

SAB Biotherapeutics Announces Offering Up To $300M Of Securities; At The Market Offering Up To $75M Of Common Stock

Benzinga·12/30/2025 15:13:05
語音播報

-SEC Filing